NIH-funded research NIH-funded research

Genetic risk screening for autism in newborns and early life follow-up

Official title: Prospective Genetic Risk Evaluation and Assessment (PROGRESS) in Autism

Funded at Columbia University Health Sciences · NIH-11413709 · Data updated 2026-11-12

This project tests how early genetic information from newborns can help identify kids at higher autism risk and guide timely care.

More Autism research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 6, 2022
Project endAugust 31, 2027
Funding year2026
Award (this year)$2,274,140
NIH project number5P50HD109879-05
Project IDNIH-11413709 on NIH RePORTER

Who could benefit from this research

Could help

Newborns in New York City who have identifiable genetic risk variants for autism and their families.

Less likely to help

Infants without identified genetic risk variants or families not opting into genetic screening may not benefit.

What this research studies

The PROGRESS Center at Columbia University will screen a large newborn population using genome sequencing to find genetic risk markers for autism. It will enroll infants with identified genetic risk and follow them over time to understand early neurobehavioral patterns and how families experience receiving genetic results. The study brings together genetics, brain development, autism diagnosis, and data science to build a foundation for earlier evaluation and potential interventions. Results could inform families and clinicians about what to expect and how to manage early autism risk. The work emphasizes careful consideration of family impact and appropriate management of the child throughout the process.

Why it matters

Potential benefit: If successful, the project could enable earlier identification and timely support for children at genetic risk of autism.

How similar studies have gone: Previous newborn screening pilots with genomic sequencing show feasibility, but this study advances predictive insights and family experience in autism risk.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Veenstra-Vanderweele, Jeremy — Columbia University Health Sciences
  • Study coordinator: Veenstra-Vanderweele, Jeremy

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.